TrialBlood2012

Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemia.

Judith E Karp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.